PeptideDB

m-Tyramine hydrobromide 38449-59-1

m-Tyramine hydrobromide 38449-59-1

CAS No.: 38449-59-1

m-Tyramine HBr is an endogenous trace amine neuromodulator. m-Tyramine HBr affects adrenergic and dopaminergic receptors
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

m-Tyramine HBr is an endogenous trace amine neuromodulator. m-Tyramine HBr affects adrenergic and dopaminergic receptors.

Physicochemical Properties


Molecular Formula C8H11NO.HBR
Molecular Weight 218.09098
Exact Mass 217.01
CAS # 38449-59-1
Related CAS # m-Tyramine;588-05-6
PubChem CID 22717856
Appearance Light yellow to yellow solid powder
LogP 2.551
Hydrogen Bond Donor Count 3
Hydrogen Bond Acceptor Count 2
Rotatable Bond Count 2
Heavy Atom Count 11
Complexity 95.3
Defined Atom Stereocenter Count 0
InChi Key RAMQGDMHEGTVQU-UHFFFAOYSA-N
InChi Code

InChI=1S/C8H11NO.BrH/c9-5-4-7-2-1-3-8(10)6-7;/h1-3,6,10H,4-5,9H2;1H
Chemical Name

3-(2-aminoethyl)phenol;hydrobromide
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat. Eur J Pharmacol. 1982 Oct 22;84(3-4):139-49.

[2]. Interactions between p-tyramine, m-tyramine, or beta-phenylethylamine and dopamine on single neurones in the cortex and caudate nucleus of the rat. Can J Physiol Pharmacol. 1980 Feb;58(2):222-7.


Solubility Data


Solubility (In Vitro) DMSO : ~125 mg/mL (~573.16 mM)
Solubility (In Vivo) Solubility in Formulation 1: ≥ 2.08 mg/mL (9.54 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 2.08 mg/mL (9.54 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.

Solubility in Formulation 3: ≥ 2.08 mg/mL (9.54 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 4.5853 mL 22.9263 mL 45.8526 mL
5 mM 0.9171 mL 4.5853 mL 9.1705 mL
10 mM 0.4585 mL 2.2926 mL 4.5853 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.